Longitude (Cayman)’s Bausch Health BHC Stock Holding History

Longitude (Cayman)’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,500	Closed	-$101K	–	59
2023 Q1	$101K	Sell	12,500 -9,500	-43%	-$76.3K	0.09%	64
2022 Q4	$138K	Buy	22,000 +5,000	+29%	+$34.9K	0.18%	62
2022 Q3	$117K	Buy	17,000 +5,000	+42%	+$34.7K	0.19%	57
2022 Q2	$100K	Buy	+12,000	New	+$168K	0.15%	54

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Longitude (Cayman)'s BHC Position: Q1 2021 in Review

Longitude (Cayman) sold out of Bausch Health (BHC) in Q1 2021, closing a stake of 220,000 shares — an estimated $4.58M sold.

Longitude (Cayman) first reported a position in BHC in Q4 2020 and held it in 1 quarter. The position peaked at $4.58M in Q4 2020. 352 funds tracked by Wall St. Rank hold BHC as of Q1 2021.

Longitude (Cayman) reported no remaining Bausch Health position as of Q1 2021 after selling out during the quarter.
Longitude (Cayman) sold 220,000 Bausch Health shares in Q1 2021, an estimated $4.58M.
Longitude (Cayman) first reported a position in Bausch Health in Q4 2020 and held it in 1 quarter.
Longitude (Cayman)'s Bausch Health position peaked at $4.58M in Q4 2020.
352 funds tracked by Wall St. Rank held Bausch Health as of Q1 2021.

Based on Longitude (Cayman)'s 13F filing for Q1 2021, filed 11 May 2021.